Utility of Therapeutic Drug Monitoring in Identifying Clinically Significant Interactions Between St. John's Wort and Prescription Drugs
Therapeutic Drug Monitoring · 2023
DOI: 10.1097/ftd.0000000000001069 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Therapeutic Drug Monitoring, 2023. Verfasst von Vanessa Steenkamp und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa; and. Hauptthemen laut MEDLINE: Prescription Drugs, Hypericum. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 81 Literaturangaben.
Abstract (Originalsprache)
Background
The general population widely uses herbal medicines, as they are regarded as effective and safe. St. John's wort, which is an effective herbal antidepressant, exhibits both pharmacokinetic and pharmacodynamic interactions with several drugs. The aim of this review was to highlight the clinically significant interactions of St. John's wort with drugs that require to be monitored to assess their therapeutic effect.
Methods
Published literature was searched using electronic databases, such as MEDLINE, PubMed, and Elsevier ScienceDirect using terms such as “herbal medicine,” “herbal toxicity,” “legislation herbal medicine,” “drug–herb interactions,” “St. John's wort,” and “St. John's wort–drug interactions.” Searches were limited to the English language, and there was no restriction on the date of publication.
Results
St. John's wort exhibits a number of pharmacokinetic and pharmacodynamic interactions with drugs. The most dangerous interactions occurred when used concurrently with the immunosuppressants, cyclosporine, and tacrolimus (treatment failure or organ rejection) or warfarin (treatment failure resulting in thromboembolic events) or antiretroviral agents (treatment failure and the emergence of new viral variants that are resistant to conventional drugs).
Conclusions
Patients should consult their health care providers before consuming herbal supplements, especially St. John's wort, to avoid potentially dangerous drug–herb interactions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology, Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa; and.
- Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, Kansas.
ORCID-Profile: Vanessa Steenkamp
Zitieren
APA
Steenkamp, V., Parkar, H., & Dasgupta, A. (2023). Utility of Therapeutic Drug Monitoring in Identifying Clinically Significant Interactions Between St. John's Wort and Prescription Drugs. Therapeutic Drug Monitoring. https://doi.org/10.1097/ftd.0000000000001069
Vancouver
Steenkamp V, Parkar H, Dasgupta A. Utility of Therapeutic Drug Monitoring in Identifying Clinically Significant Interactions Between St. John's Wort and Prescription Drugs. Therapeutic Drug Monitoring. 2023. doi:10.1097/ftd.0000000000001069
BibTeX
@article{Steenkamp2023,
author = {Steenkamp, Vanessa and Parkar, Hafiza and Dasgupta, Amitava},
title = {Utility of Therapeutic Drug Monitoring in Identifying Clinically Significant Interactions Between St. John's Wort and Prescription Drugs},
journal = {Therapeutic Drug Monitoring},
year = {2023},
doi = {10.1097/ftd.0000000000001069}
}
EUVIMED